Julie A. Murphy

728 total citations
44 papers, 507 citations indexed

About

Julie A. Murphy is a scholar working on Public Health, Environmental and Occupational Health, Geriatrics and Gerontology and General Health Professions. According to data from OpenAlex, Julie A. Murphy has authored 44 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 10 papers in Geriatrics and Gerontology and 7 papers in General Health Professions. Recurrent topics in Julie A. Murphy's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Innovations in Medical Education (7 papers) and Epilepsy research and treatment (4 papers). Julie A. Murphy is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Innovations in Medical Education (7 papers) and Epilepsy research and treatment (4 papers). Julie A. Murphy collaborates with scholars based in United States, Australia and Belgium. Julie A. Murphy's co-authors include Edna I. Rawlings, Steven R. Howe, Matthew J. Silva, Paul Shaughnessy, Peter A. McSweeney, Miguel Islas‐Ohlmayer, Kurt Winkler, Michael B. Maris, Alicia B. Forinash and Michael Steinberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Julie A. Murphy

40 papers receiving 483 citations

Peers

Julie A. Murphy
Jan McKendrick United States
Michael Grabner United States
Julie Marker Australia
Amy K. O’Sullivan United States
Mi Sook Song South Korea
Jamie M. Stagl United States
Homa Keshavarz Canada
Lindsay Jones United Kingdom
Aurel O. Iuga United States
Yongan Sun China
Jan McKendrick United States
Julie A. Murphy
Citations per year, relative to Julie A. Murphy Julie A. Murphy (= 1×) peers Jan McKendrick

Countries citing papers authored by Julie A. Murphy

Since Specialization
Citations

This map shows the geographic impact of Julie A. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Murphy more than expected).

Fields of papers citing papers by Julie A. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Murphy. The network helps show where Julie A. Murphy may publish in the future.

Co-authorship network of co-authors of Julie A. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Murphy. A scholar is included among the top collaborators of Julie A. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Murphy. Julie A. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Julie A., et al.. (2025). Evaluation of burnout among pharmacy residents in the United States. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(7). 533–538.
2.
Flannery, Alexander H., et al.. (2024). 2023 update to the American College of Clinical Pharmacy Pharmacotherapy Didactic Curriculum Toolkit. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(3). 255–269. 16 indexed citations
3.
Kim, Richard D., Hirva Mamdani, Minal Barve, et al.. (2024). A phase 2a study of NT-I7 (efineptakin alfa), a long-acting IL-7, and pembrolizumab to evaluate efficacy, including overall survival, in hard-to-treat gastrointestinal tumors.. Journal of Clinical Oncology. 42(16_suppl). 2621–2621. 1 indexed citations
4.
Murphy, Julie A., et al.. (2024). Identification of Risk Factors for Imposter Syndrome Among Healthcare Professional Students. American Journal of Pharmaceutical Education. 88(9). 100808–100808. 2 indexed citations
5.
6.
Naing, Aung, Hirva Mamdani, Minal Barve, et al.. (2023). 652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors. SHILAP Revista de lepidopterología. A743–A743. 1 indexed citations
7.
Conrad, Paula, et al.. (2023). Identifying risk factors for pediatric central-line–associated bloodstream infections. SHILAP Revista de lepidopterología. 3(S2). s45–s45.
8.
9.
Murphy, Julie A., et al.. (2020). Interviewer perceptions during the implementation of the multiple mini-interview model at a school of pharmacy. Currents in Pharmacy Teaching and Learning. 12(7). 864–871. 1 indexed citations
10.
Murphy, Julie A., et al.. (2018). Evaluation of Bronchodilator Use During Chronic Obstructive Pulmonary Disease Exacerbation Inpatient Admissions. Hospital Pharmacy. 54(2). 112–118. 2 indexed citations
11.
12.
Peeters, Michael J., et al.. (2015). Comparing Vertical and Horizontal Screening Methods for Pharmacy Resident Candidates Before Interviews. SHILAP Revista de lepidopterología. 6(3). 2 indexed citations
13.
Murphy, Julie A., et al.. (2014). Vortioxetine for the Treatment of Depression. Annals of Pharmacotherapy. 48(6). 758–765. 19 indexed citations
14.
Murphy, Julie A., et al.. (2014). Drugs in Perspective: Liraglutide for the treatment of obesity. 1 indexed citations
15.
Grice, Gloria R., et al.. (2012). Health literacy: Use of the Four Habits Model to improve student pharmacists’ communication. Patient Education and Counseling. 90(1). 23–28. 25 indexed citations
16.
Murphy, Julie A., et al.. (2010). Lacosamide and Epilepsy. CNS Neuroscience & Therapeutics. 17(6). 678–682. 18 indexed citations
17.
Murphy, Julie A.. (2010). Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis. Neuropsychiatric Disease and Treatment. 6. 619–619. 5 indexed citations
18.
Murphy, Julie A., et al.. (2009). Lacosamide: An Adjunctive Agent for Partial-Onset Seizures and Potential Therapy for Neuropathic Pain. Annals of Pharmacotherapy. 43(11). 1809–1817. 18 indexed citations
19.
20.
Murphy, Julie A.. (2004). The Use of Sexual Orientation-Related Insults Among College Students. OhioLink ETD Center (Ohio Library and Information Network). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan McKendrick Breakdown of academic impact, for papers by Michael Grabner Breakdown of academic impact, for papers by Julie Marker Breakdown of academic impact, for papers by Amy K. O’Sullivan Breakdown of academic impact, for papers by Mi Sook Song Breakdown of academic impact, for papers by Jamie M. Stagl Breakdown of academic impact, for papers by Homa Keshavarz Breakdown of academic impact, for papers by Lindsay Jones Breakdown of academic impact, for papers by Aurel O. Iuga Breakdown of academic impact, for papers by Yongan Sun
Rankless by CCL
2026